Case CCC brings together @cwru, @UHhospitals, and @ClevelandClinic to unlock new possibilities in cancer research and transform the landscape of cancer care.
Join us tomorrow as we welcome Andrew Dhawan, MD DPhil FRCPC, @clevelandclinic, for the upcoming seminar: "Every Patient, More Signal: Data Science in Neuro-Oncology." 12pm | Biomedical Research Building Auditorium. Click here to view the livestream: https://t.co/h89yvOJ0P8
CanSUR summer 2027 applications open Oct 30! Are you an undergrad interested in cancer research? Case CCC Cancer-focused Summer Undergraduate Research Program (CanSUR) gives students hands-on experience. Learn more: https://t.co/BFROT9ucyl
@CWRUSOM@UHhospitals@ClevelandClinic
Join us Friday for our seminar with Brock Humphries, PhD, of the University of Michigan’s Rogel Cancer Center: "How Cell-to-Cell Mitochondrial Transfer Drives Breast Cancer."
🔵Fri, Oct 16 | 12-1
🔵Free & open to the public. Complimentary lunch provided.
Researchers at Case CCC have found that the structure of collagen may provide clues about how triple-negative breast cancer (TNBC) could progress, linked to cancer recurrence and survival. Read the story: https://t.co/HUrnGVB5xD
Case CCC & @CWRUSOM researchers have identified a rare type of small cell lung cancer that may respond differently to certain treatments. Understanding these differences could help guide future research into more personalized cancer care. Read more: https://t.co/4dfPj7o5nv
Platelet count. Anemia. Cytopenia status. Aaron Gerds, MD, MS explains how these factors are reshaping JAK inhibitor selection in myelofibrosis this Blood Cancer Awareness Month.
Watch the full video series: https://t.co/4dsb5Htpsy
@AaronGerds@caseccc#Myelofibrosis #JAKInhibitors #BloodCancerAwarenessMonth
Great to be with friends at the @theABTA#AARN2026 meeting - great representation from Cleveland institutes @caseccc@CCLRI - looking forward to continuing the collaborations!
Official Miller Family team picture for @bikeVeloSano 2026! Ready to ride this morning to raise funds for cancer research at the Case Comprehensive Cancer Center!
@caseccc#velosano 100% for the Cure
If you are able to support:
Tyler: https://t.co/slRJZLLSHs
Brittany: https://t.co/Pf7T3sxWav
Skyler: https://t.co/NihWHSek4B
Zander: https://t.co/sESCIpyRQ4
@CWRUSOM
Congratulations to my graduate student Tenesha Connor on receiving the Andrew Parsa Young Investigator Award at @NeuroOnc! She leads our glioblastoma research, and I’m proud to see her work recognized by the neuro-oncology community. Looking forward to her presentation in Phili!
Join us tomorrow for the Case CCC Seminar Series featuring Christina Jackson, MD (@PennMedicine, @PennCancer), exploring the latest discoveries in cancer research.
🔵 12–1 p.m. | BRB 105
🔵 Free light lunch
🔵 Free & open to the public
New research from Case CCC found that a common antihistamine improved blood-cell recovery in laboratory studies, pointing to a potential new approach after bone marrow injury or transplantation.
Read more: https://t.co/GvTFGFO4vQ
Join us tomorrow for the Case CCC Seminar Series featuring Zhenghe J. Wang, PhD, exploring the latest discoveries in cancer research.
🔵 12–1 p.m. | BRB 105
🔵 Free light lunch
🔵 Free & open to the public
We're gearing up for @VeloSano’s @ClevelandClinic Bike to Cure on Sept. 19! Ride with us: every dollar raised by Case CCC riders directly supports cancer research. Register with our team and we’ll cover your registration fee! Email Carolyn Hicks at [email protected] for the code.
Can doctors diagnose AL amyloidosis earlier? Case CCC member Shahzad Raza, MD (@ClevelandClinic) helped develop the first ASH guidelines for diagnosing this rare, life-threatening disease: https://t.co/hrwjJ8EIWU
Could a simple mouth swab help dentists find oral cancer sooner? Case CCC researchers are developing a new test that can tell within MINUTES whether a suspicious spot needs a biopsy. Learn more: https://t.co/1DnNdYSMb0
A discovery in cancer biology is taking researchers somewhere unexpected: brain health. 🧠
Case CCC member Sanford Markowitz, MD, PhD, and Andrew Pieper, MD, PhD, are exploring 15-PGDH as a potential target for protecting the brain.
Read more: https://t.co/vTyHshcKA4